Keybank National Association Cytokinetics Inc Transaction History

Keybank National Association

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$34.35 - $46.38 $2.6 Million - $3.51 Million	-75,692 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$18.54 - $35.74 $1.4 Million - $2.71 Million	75,692 New	75,692 $2.53 Million
Q4 2018 Jan 30, 2019	SELL	$5.91 - $9.29 $129,216 - $203,116	-21,864 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$6.4 - $9.85 $41,299 - $63,562	-6,453 Reduced 22.79%	21,864 $215,000
Q2 2018 Aug 08, 2018	BUY	$6.9 - $9.9 $45,208 - $64,864	6,552 Added 30.1%	28,317 $235,000
Q4 2017 Feb 08, 2018	BUY	$7.25 - $15.65 $39,614 - $85,511	5,464 Added 33.52%	21,765 $177,000
Q3 2017 Nov 02, 2017	SELL	$12.0 - $15.0 $86,244 - $107,805	-7,187 Reduced 30.6%	16,301 $236,000
Q2 2017 May 14, 2018	SELL	N/A	-1,130 Reduced 4.59%	23,488 $284,000
Q1 2017 May 14, 2018	SELL	N/A	-15,586 Reduced 38.77%	24,618 $316,000
Q4 2016 May 14, 2018	BUY	N/A	40,204	40,204 $488,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.